Drugs / ClinOleic 20%®
last change Dec 2007 re-read 2 minutes ago

ClinOleic 20%®

Other / unclassified

Developed for
inflammatory disease

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00600912 Comparator Dec 2006 → Dec 2007 inflammatory disease Klinikum Ludwigshafen Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ClinOleic 20% ClinicalTrials.gov intervention name — accepted as the source's own label NCT00600912
Known as ClinOleic 20% (Baxter Deutschland GmbH,Unterschleissheim, Germany) “ClinOleic 20%® (Baxter Deutschland GmbH,Unterschleissheim, Germany)” NCT00600912
Modality Other / unclassified “a lipid emulsion based on olive and soybean oil” NCT00600912